Viking Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops and markets therapies for metabolic and endocrine disorders. With a focus on innovative approaches, Viking is committed to improving the lives of patients suffering from conditions like non-alcoholic steatohepatitis (NASH) and hip fractures.
